Assessing treatment value under uncertainty: Measuring treatment value for a new treatment for cognitive impairment
Jason Shafrin, Kyi‐Sin Than, Jaehong Kim, Jacob Fajnor, Elizabeth S Mearns, Stacey L Kowal, Thomas Majda, Jakub Hlavka · 2025
Read Assessing treatment value under uncertainty: Measuring treatment value for a new treatment for cognitive impairment by Jason Shafrin, Kyi‐Sin Than, Jaehong Kim, Jacob Fajnor, Elizabeth S Mearns, Stacey L Kowal, Thomas Majda, Jakub Hlavka (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11714683.txt.
Description
Jason Shafrin and co-authors measured how people value a new treatment for memory and thinking loss in 2025. Standard cost studies often ignore how severe the illness is at the start. The team asked whether people also value cover that protects them if severe dementia comes later.
A survey of adults in the United States used a staircase method to find what each person would pay each year for such cover. The stated amount was about two and a half times the value from standard methods. Respondents also showed clear risk aversion. The authors argue that standard methods may understate what these treatments are worth to patients.
Catalog record
| CREATOR | Jason Shafrin, Kyi‐Sin Than, Jaehong Kim, Jacob Fajnor, Elizabeth S Mearns, Stacey L Kowal, Thomas Majda, Jakub Hlavka |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 3 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |